- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
The trading panel looked at Twitter, Alibaba and GoPro.
12/24/14 - 05:00 AM EST
The trading panel discussed stocks, the price of oil, Twitter and Abbvie's price cuts on hepatitus C drugs.
12/23/14 - 05:00 AM EST
Which biotech and pharmaceuticals stocks should investors buy in 2015? JPMorgan named six companies with the best investment cases as part of its top U.S. stocks picks for 2015.
12/22/14 - 08:23 AM EST
CNBC's 'Fast Money Halftime' trading panel looked at some of the driving forces behind the recent stock market rally.
12/19/14 - 02:34 PM EST
The trading panel discussed energy companies, Nike and other retailers.
12/19/14 - 05:00 AM EST
CNBC's 'Fast Money Halftime' trading panel looked at the S&P 500's rally, which continues to gain steam thanks to the Federal Reserve.
12/18/14 - 02:45 PM EST
The trading panel discussed the Federal Reserve, being patient and whether the stock market will rebound anytime soon.
12/18/14 - 05:00 AM EST
The trading panel discussed how low the S&P 500 should go before investors can consider getting long again.
12/17/14 - 05:00 AM EST
The CNBC 'Fast Money Halftime' trading panel looked at oil prices and Russia, which has heightened volatility in the stock market.
12/16/14 - 02:53 PM EST
The trading panel discussed falling oil prices, the Russian ruble and Twitter.
12/16/14 - 05:00 AM EST
The CNBC 'Fast Money Halftime' trading panel sees good buying opportunities in the market.
12/15/14 - 02:52 PM EST
The trading panel discussed whether the current stock market pullback means this is the time to buy.
12/13/14 - 05:00 AM EST